FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11831236.2

公开号：

EP2621925B1

申请日:

2011.09.26

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

This invention relates to novel fused tricyclic compounds that are inhibitors of mammalian Target of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP, and are useful in the treatment of cellular proliferative diseases, for example cancer and other proliferative disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/